Cipherome, Inc

📍 San Jose, United States👥 19 employees💰 Last funded 2017
Biotechnology Research🌐 cipherome.com
Website LinkedIn
Cipherome, Inc. is a unique software-based pharmacogenomics (PGx) and bioinformatics company focused on accurately predicting adverse drug reactions (ADRs). Comprised of a highly credible team with extensive experience in bioinformatics, advanced genomic sequence analysis algorithms, drug development, and clinical expertise, Cipherome has developed a Xentinel ™, a proprietary personalized drug safety and biomarker discovery platform. Our goal is to reduce the economic, emotional, and societal burden of ADRs. Please visit us at www.cipherome.com to learn more about what we do.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Cipherome, Inc?
Cipherome, Inc has 1 investors on record on gritt.io.
When did Cipherome, Inc last raise funding?
The most recent investment in Cipherome, Inc recorded on gritt.io was in 2017.
What industry is Cipherome, Inc in?
Cipherome, Inc operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cipherome, Inc based?
Cipherome, Inc is headquartered in San Jose, United States.